$429.69
0.05%
NYSE, Nov 13, 04:27 pm EST. Closed.
ISIN
US0367521038
Symbol
ELV

Elevance Health Stock price

$429.69
+4.42 1.04% 1M
+30.05 7.52% 6M
+79.14 22.58% YTD
+101.41 30.89% 1Y
-31.70 6.87% 3Y
-4.70 1.08% 5Y
+291.09 210.02% 10Y
+356.47 486.85% 20Y
NYSE, Closing price Fri, Nov 13 2026
-0.21 0.05%

AI Insights on Elevance Health Insights AI Insights on Elevance Health

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Is Elevance Health a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,087 stocks worldwide.

Key metrics

Basic
Market capitalization
$92.8b
Enterprise Value
$113.2b
Net debt
$20.4b
Cash
$10.3b
Shares outstanding
216.1m
Valuation
P/E
18.2
P/S | estimate
0.5 | 0.5
EV/Sales | estimate
0.6 | 0.6
EV/FCF | ex SBC
17.4 | 18.1
P/B
2.1
Dividends
DPS
$6.88
Yield 1Y | 5Y
1.6% | 1.4%
Growth 1Y | 5Y
0.6% | 8.8%
Payout 1Y | 3Y
27.1% | 25.3%
Increased
16 Years
Financials
Revenue | estimate
$201.8b | $201.4b
EBITDA
$8.2b
EBIT
$7.7b
Net Income
$5.1b
Free Cash Flow | ex SBC
$6.5b | $6.3b
Growth
Revenue | estimate
3.6% | 1.1%
EBITDA
-10.0%
EBIT
-9.0%
Net Income
-7.1%
Free Cash Flow
75.1%
Margin
Gross
-
EBITDA
4.1%
EBIT
3.8%
Net
2.6%
Free Cash Flow | ex SBC
3.2% | 3.1%
Financial Health
Equity Ratio
36.1%
Return on Equity
12.9%
ROCE
6.5%
ROIC
5.8%
Debt/Equity
0.7
Share-Based Compensation & Dilution
SBC | % of Revenue
$240.0m | 0.1%
SBC as % of FCF
3.7%
SBC Growth 1Y
10.6%
Share Count Growth 1Y
-2.7%
Shareholder Yield
4.3%
More
EPS
$23.6
FCF per Share
$30.1
Short interest
2.4%
Employees
97k
Rev per Employee
$2.1m

Elevance Health Stock Analysis

Unlock Scores for Free

Analyst Opinions

28 Analysts have issued a Elevance Health forecast:

19x Buy
68%
9x Hold
32%

Analyst Opinions

28 Analysts have issued a Elevance Health forecast:

Buy
68%
Hold
32%

Elevance Health Events

Past Events
OCT
21
Q3 2026 Earnings Call
26 days ago
SEP
10
Wells Fargo 21st Annual Healthcare Conference
2 months ago
JUL
15
Q2 2026 Earnings Call
4 months ago
JUN
10
Goldman Sachs 47th Annual Global Healthcare Conference 2026
5 months ago
MAY
13
Shareholder/Analyst Call - Elevance Health, Inc.
6 months ago
APR
22
Q1 2026 Earnings Call
7 months ago
MAR
10
Barclays 28th Annual Global Healthcare Conference
8 months ago
JAN
28
Q4 2025 Earnings Call
10 months ago
NOV
11
UBS Global Healthcare Conference 2025
about one year ago
OCT
21
Q3 2025 Earnings Call
about one year ago

Financial data from Elevance Health

Sep '26
+/-
%
201,831 201,831
4% 4%
100%
- Policy Benefits 148,483 148,483
3% 3%
74%
53,348 53,348
4% 4%
26%
- SG&A - -
-
-
- Other operating expenses 45,143 45,143
7% 7%
22%
8,205 8,205
10% 10%
4%
- Depreciation and Amortization 492 492
24% 24%
0%
7,713 7,713
9% 9%
4%
- Interest Expense 1,445 1,445
5% 5%
1%
- Tax Expense 1,147 1,147
27% 27%
1%
Net Profit 5,139 5,139
7% 7%
3%

In millions USD.

Don't miss a Thing! We will send you all news about Elevance Health directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Elevance Health Stock News

Neutral
Business Wire
●
4 days ago
OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has assigned indicative Long-Term Issue Credit Ratings of “bbb+” (Good) to senior unsecured issues, “bbb” (Good) to subordinated issues and “bbb-” (Good) to preferred stock issues to the recently filed shelf registrations of Elevance Health, Inc. (Elevance Health) (Indianapolis, IN) [NYSE: ELV]. The outlook assigned to these Credit Ratings (r...
Negative
WSJ
●
11 days ago
Elevance Health sued autism-therapy provider the Perfect Child, alleging that it paid the company $160 million due to misleading claims over the last five years.
More Elevance Health News

Company Profile

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Commercial and Specialty Business, Government Business, CarelonRx, and Other. The Commercial and Specialty Business segment provides insurance products and services such as stop loss, dental, vision, life, disability and supplemental health insurance. The Government Business segment includes medicare and medicaid businesses, national government services, and services provided to the federal government. The CerelonRx segment offers formulary management, pharmacy networks, prescription drug database, member services, and mail order capabilities. The Other segment is involved in health services business focused on quality of healthcare by enabling and creating new care delivery and payment models. The company was founded in 1944 and is headquartered in Indianapolis, IN.

Head office United States
CEO Ms. Boudreaux
Employees 96,615
Founded 1944
Website www.elevancehealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today